# Rigel Pharmaceuticals Inc: Form 8-K, filed Feb 18, 2021

- Company: [Rigel Pharmaceuticals Inc](/companies/rigl.md) (CIK 1034842)
- Form: 8-K
- Filed: 2021-02-18
- Accepted by EDGAR: Feb 18, 2021, 06:30 ET
- Period: 2021-02-18
- Accession: 0001104659-21-025010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1034842/000110465921025010/tm215880d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1034842/000110465921025010/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1034842/000110465921025010/tm215880d1_8k.htm

Filed Feb 18, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-025010. Last ingested by Listed: Nov 14, 2026, 23:09 ET. No prices; not investment advice.
